CRT 2026 Faculty Agreement to Participate

Faculty(s)

• DL

  David P. Lee, MD

  Professor of Medicine
  Stanford University
  Stanford, California, United States

  Disclosure information not submitted.
• ML

  Michael S. Lee, MD, FACC, FSCAI

  Chief of Cardiology, Interventional Cardiologist
  Griffin Hospital
  LOS ANGELES, California, United States

  Disclosure(s): No financial relationships to disclose
• 

  Massoud Leesar, MD

  Professor of Medicine, Section head-Interventional cardiology
  UAB
  Birmingham, Alabama, United States

  Disclosure(s): No financial relationships to disclose
• 

  Martin B. Leon, MD, FSCAI

  Mallah Family Professor of Cardiology at the Columbia University Irving Medical Center College of Physicians and Surgeons and Chief Innovations Officer and Director, Cardiovascular Data Science Center at New York-Presbyterian Hospital/Columbia University Medical Center Director, Columbia Interventional Cardiovascular Care/Founder and Chairman Emeritus, Cardiovascular Research Foundation
  Cardiovascular Research Foundation / Columbia University Medical Center
  New York, New York, United States

  Disclosure information not submitted.
• 

  Stamatios Lerakis, MD

  Director of Noninvasive Cardiology
  Mount Sinai Heart
  New York, New York, United States

  Disclosure(s): No financial relationships to disclose
• 

  Amir Lerman, MD

  Consultant
  Mayo Clinic
  Rochester, Minnesota, United States

  Disclosure(s): Philips: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Peter Libby, MD

  Cardiovascular Specialist
  Brigham and Women's Hospital
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Scott M. Lilly, MD PhD

  Professor
  The Ohio State University Wexner Medical Center
  Columbus, Ohio, United States

  Disclosure information not submitted.
• 

  Scott Lim, MD

  Professor of Medicine
  University of British Columbia
  Vancouver, British Columbia, Canada

  Disclosure information not submitted.
• 

  Michael J. Lim, MD

  Interventional Cardiologist
  Poplar Bluff Regional Medical Center
  Poplar Bluff, Missouri, United States

  Disclosure information not submitted.
• 

  JoAnn Lindenfeld, MD

  Director, Heart Failure and Transplantation
  Vanderbilt University
  Nashville, Tennessee, United States

  Disclosure information not submitted.
• 

  Reginald I. Low, MD

  Chief, Division of Cardiovascular Medicine
  University of California, Davis
  Sacramento, CA, United States

  Disclosure information not submitted.
• 

  Michael J. Mack, MD

  Chair, Cardiovascular Servivce Line
  Heart Hospital Baylor Plano
  Plano, Texas, United States

  Disclosure information not submitted.
• 

  Ryan D. Madder, MD

  Section Chief of Interventional Cardiology & Director of Cardiac Cath Lab
  Corewell Health
  Ada, Michigan, United States

  Disclosure information not submitted.
• 

  Ehtisham Mahmud, MD, FACC, FSCAI

  Chief, Cardiovascular Medicine
  UC San Diego
  La Jolla, CA, United States

  Disclosure information not submitted.
• 

  Paul D. Mahoney, MD, FACC, FSCAI

  Chief, Interventional Cardiology, Director, Structural Heart Program
  ECU Health
  Greenville, North Carolina, United States

  Disclosure information not submitted.
• 

  Arasi Maran, MD

  Associate Professor
  Medical University of South Carolina
  Charleston, South Carolina, United States

  Disclosure information not submitted.
• 

  S. Kimara March, MS MD

  Adult Congenital and Interventional Cardiologist Regional ECMO Director
  University of Minnesota Physicians Heart
  Minneapolis , Minnesota, United States

  Disclosure information not submitted.
• 

  Fadi A. Matar, MD, FACC, FSCAI

  Professor of Medicine, Chief of Cardiology
  University of South Florida
  Tampa, Florida, United States

  Disclosure(s): No financial relationships to disclose
• 

  S. Jay Mathews, MD

  Director, Cardiac Cath Lab, PERT, & Structural Heart
  Manatee Memorial Hospital

  Disclosure information not submitted.
• 

  Mat Maurer, MD

  Professor
  Columbia University

  Disclosure information not submitted.
• 

  James McCabe, MD

  Section Chief, Interventional Cardiology
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Michael Megaly, MD

  Interventional cardiologist
  Ascension St John Medical Center
  Tulsa, Oklahoma, United States

  Disclosure information not submitted.
• 

  Mandeep R. Mehra, MD, MSc, FRCP

  William Harvey Chair in Cardiovascular Medicine
  Brigham and Women's Hospital
  Needham, Minnesota, United States

  Disclosure information not submitted.
• 

  Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI

  Professor of Cardiology and Population Health Science and Policy, Mount Sinai Endowed Professor in Cardiovascular Clinical Research and Outcomes; Director of Interventional Cardiovascular Research and Clinical Trials; Director of Women’s Heart and Vascular Center at Mount Sinai Heart
  Icahn School of Medicine at Mount Sinai, New York
  New York, New York, United States

  Disclosure(s): Abbott, Alleviant Medical, Chiesi, Concept Medical, Cordis, CPC Clinical Research, Daiichi Sankyo, Duke, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Medtronic, NewAmsterdam Pharma, Novartis, Novo Nordisk Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); AMA - JAMA Cardiology (Associate Editor), ACC (Vice President, BOT Member, SC Member CTR Program): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elixir Medical, Stel, ControlRad (spouse): Stock Options [in privately held companies] (Ongoing); Population Health Research Institute (PHRI), Protembis GmbH, Radcliffe, RM Global Bioaccess Fund Management, Sanofi US Services, Inc. ;: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director): No Fees (Ongoing)
• 

  Sameer Mehta, MD

  Chairman
  Lumen Foundation
  Miami, Florida, United States

  Disclosure(s): No financial relationships to disclose
• 

  Perwaiz M. Meraj, MD, FSCAI

  Director of Interventional Cardiology and Cardiac Catheterization Laboratory
  Northwell Health
  Manhasset, New York, United States

  Disclosure information not submitted.
• 

  Ezequiel J. Molina, MD

  Surgical Director, Advanced Heart Failure and LVAD Program.
  Piedmont Heart Institute
  Atlanta, Georgia, United States

  Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  David J. Moliterno, MD

  Professor of Internal Medicine
  University of Kentucky
  Lexington, Kentucky, United States

  Disclosure information not submitted.
• 

  Michael R. Mooney, MD, FACC, FAHA, FSCAI

  Director, Coronary Therapeutics
  Minneapolis Heart Institute at Abbott Northwestern Hospital
  Minneapolis, Minnesota, United States

  Disclosure information not submitted.
• 

  Pedro R. Moreno, MD, FACC

  Director - Quality Assurance for Cardiology
  Mount Sinai Hospital
  New York, New York, United States

  Disclosure information not submitted.
• 

  Jeffrey W. Moses, MD, FSCAI

  John and Myrna Daniels Professor of Cardiology
  Columbia University Medical Center
  New York, New York, United States

  Disclosure information not submitted.
• 

  Issam Moussa, MD

  Medical Director, Carle Heart & Vascular Institte
  Carle Health / University of Illinois Urbana Champaign
  Dallas, Texas, United States

  Disclosure(s): No financial relationships to disclose
• 

  James E. Muller, MD

  Cardiologist, Brigham and Women's Hospital, Boston, MA 02115
  Brigham and Women's Hospital
  Auburndale , Massachusetts, United States

  Disclosure(s): echas llc: Stock-privately held company (Ongoing); Spectrawave: Stock-privately held company (Ongoing)
• 

  Jihad A. Mustapha, MD FACC FSCAI

  Interventional Cardiologist
  Lorven Heart & Vascular Institute
  Ada , Michigan, United States

  Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing); Cagent Vascular: Stock Options [in privately held companies] (Ongoing); Cardioflow: board member/chief medical officer, equity ownership (Ongoing), Stock-privately held company (Ongoing); Euphrates: Stock Options [in privately held companies] (Ongoing); Glift: Stock Options [in privately held companies] (Ongoing); Iatri: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Immertec: Stock Options [in privately held companies] (Ongoing); Levee Medical: Stock Options [in privately held companies] (Ongoing); Micromedical Solutions: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Reflow Medical: Grant/Research Support (Ongoing), scientific advisory board (Ongoing), Stock-privately held company (Ongoing); SoundBite Medical: Stock-privately held company (Ongoing); Transit Medical: Stock Options [in privately held companies] (Ongoing); Versono: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Srihari S. Naidu, MD, FSCAI

  Director, Cath Labs and HCM Program
  Westchester Medical Center
  Valhalla, New York, United States

  Disclosure information not submitted.
• 

  Devi G. Nair, MD , FACC, FHRS

  Director of Cardiac Electrophysiology
  St. Bernards Medical Center
  JONESBORO, Arkansas, United States

  Disclosure information not submitted.
• 

  Aravinda Nanjundappa, MD, FSCAI

  Director of Peripheral Vascular Interventions, Cardiovascular Division
  Cleveland Clinic , Main Campus
  Pepper pike, Ohio, United States

  Disclosure information not submitted.
• 

  Sandeep Nathan, MD, MSc

  Professor of Medicine Medical Director, Cardiac ICU Co-Director, Cardiac Catheterization Laboratory Director, Interventional Cardiology Fellowship Program
  University of Chicago Medicine
  Chicago, Illinois, United States

  Disclosure information not submitted.
• TN

  Tamim Nazif, MD

  Disclosure information not submitted.
• 

  Saroj Neupane, MD

  Interventional Cardiologist
  WakeMed Hospital, Raleigh, North Carolina
  Phoenix , Arizona, United States

  Disclosure information not submitted.
• 

  Tom Nguyen, MD

  Director of Minimally Invasive Valve Surgery
  The University of Texas at Houston
  Houston, TX

  Disclosure information not submitted.
• 

  Khusrow A. Niazi, MD, FACC, FSCAI, FSVM

  Director Peripheral Vascular Interventions
  Emory University
  Dunwoody, Georgia, United States

  Disclosure information not submitted.
• 

  Bill Nicholson, MD

  Director of Interventional Cardiology
  Emory Healthcare
  York, Pennsylvania, United States

  Disclosure information not submitted.
• 

  Magnus Ohman, MD, FRCPI, FESC, FACC, FSCAI

  Professor of Medicine
  Duke University Medical Center
  Durham, North Carolina, United States

  Disclosure information not submitted.
• 

  William W. O'Neill, MD, FACC, MSCAI

  emeritus Medical Director
  Henry Ford Health Systems
  Detroit, Michigan, United States

  Disclosure information not submitted.
• BO

  Brian O'Neill, MD

  Director of Structural Heart and Interventional Cardiology Research
  Henry Ford Hospital, Detroit MI

  Disclosure information not submitted.